Journal for Immunotherapy of Cancer

The Journal for ImmunoTherapy of Cancer (JITC) is a peer-reviewed publication that promotes scientific exchange and deepens knowledge in the constantly evolving fields of tumor immunology and cancer immunotherapy. With an open access format, JITC encourages widespread access to its findings. The journal covers a wide range of topics, spanning from basic science to translational and clinical research. Key areas of interest include tumor-host interactions, the intricate tumor microenvironment, animal models, the identification of predictive and prognostic immune biomarkers, groundbreaking pharmaceutical and cellular therapies, innovative vaccines, combination immune-based treatments, and the study of immune-related toxicity.

《癌症免疫治疗杂志》(JITC)是一份同行评审出版物，旨在促进肿瘤免疫学和癌症免疫治疗不断发展的领域的科学交流并加深知识。JITC采用开放获取格式，鼓励广泛获取其研究结果。该杂志涵盖广泛的主题，从基础科学到转化和临床研究。感兴趣的关键领域包括肿瘤-宿主相互作用、复杂的肿瘤微环境、动物模型、预测和预后免疫生物标志物的识别、突破性的药物和细胞疗法、创新疫苗、基于免疫的联合治疗以及免疫相关毒性的研究。